TCIM
ATYR

TIAA CREF Investment Management’s aTyr Pharma ATYR Stock Holding History

TIAA CREF Investment Management’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,385
Closed -$76K – 3194
2016
Q1 		$76K Hold
1,385
– – ﹤0.01% 3044
2015
Q4 		$191K Hold
1,385
– – ﹤0.01% 3073
2015
Q3 		$199K Sell
1,385
-1,670
-55% -$381K ﹤0.01% 3042
2015
Q2 		$792K Buy
+3,055
New +$949K ﹤0.01% 2814

Other funds holding ATYR

RCM
Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TIAA CREF Investment Management's ATYR Position: Q2 2016 in Review

TIAA CREF Investment Management sold out of aTyr Pharma (ATYR) in Q2 2016, closing a stake of 1,385 shares — an estimated $76K sold.

TIAA CREF Investment Management first reported a position in ATYR in Q2 2015 and held it in 4 quarters. The position peaked at $792K in Q2 2015. 49 funds tracked by Wall St. Rank hold ATYR as of Q2 2016.

  • TIAA CREF Investment Management reported no remaining aTyr Pharma position as of Q2 2016 after selling out during the quarter.
  • TIAA CREF Investment Management sold 1,385 aTyr Pharma shares in Q2 2016, an estimated $76K.
  • TIAA CREF Investment Management first reported a position in aTyr Pharma in Q2 2015 and held it in 4 quarters.
  • TIAA CREF Investment Management's aTyr Pharma position peaked at $792K in Q2 2015.
  • 49 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2016.

Based on TIAA CREF Investment Management's 13F filing for Q2 2016, filed 11 Aug 2016.